For many individuals, semaglutide provides a more focused and tolerable option
Depending on your treatment goals, other medications such as metformin may also be considered
You feel fuller sooner during meals, you stay satisfied longer between meals, and youre less likely to experience sudden hunger pangs or cravings
Federal rules prevent Medicare from covering medications that are used only for weight loss
Currently available GLP-1 receptor agonists in the United States include exenatide (Byetta, Bydureon BCise), liraglutide (Victoza, Saxenda), dulaglutide (Trulicity), semaglutide (Ozempic, Wegovy, Rybelsus), and tirzepatide (Mounjaro, Zepbound), though tirzepatide is technically a dual GIP/GLP-1 receptor agonist
Yet unanswered questions regarding this program remain, and the FAQs note that further information will be released in spring 2026